Cargando…

Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty

BACKGROUND: Evidence on antibiotic-loaded bone cement remains too vague to guide kyphoplasty in patient care. We clinically evaluated the properties and benefits of a new low viscosity polymethylmethacrylate (PMMA) bone cement loaded with gentamicin. METHODS: In this non-randomised, monocentric, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Opalko, Maciej, Bösebeck, Hans, Vogt, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660699/
https://www.ncbi.nlm.nih.gov/pubmed/31351477
http://dx.doi.org/10.1186/s13018-019-1200-3
_version_ 1783439352806768640
author Opalko, Maciej
Bösebeck, Hans
Vogt, Sebastian
author_facet Opalko, Maciej
Bösebeck, Hans
Vogt, Sebastian
author_sort Opalko, Maciej
collection PubMed
description BACKGROUND: Evidence on antibiotic-loaded bone cement remains too vague to guide kyphoplasty in patient care. We clinically evaluated the properties and benefits of a new low viscosity polymethylmethacrylate (PMMA) bone cement loaded with gentamicin. METHODS: In this non-randomised, monocentric, prospective open trial, 50 consecutively enrolled patients with fractures of the vertebral body (TH7-L4) due to osteoporosis or trauma were investigated between 2010 and 2013, with a 1-year post-op follow-up per patient. The antibiotic-loaded PMMA bone cement was administered to patients during the surgery according to the standard procedure established on site for one-staged kyphoplasty. The clinical outcome was assessed according to function and pain by standardised anamnesis, clinical investigation, validated visual analogue scale (VAS) vertebral spine score, Oswestry Low-Back-Pain (ODI) Disability score, and Short Form (SF)-36 score. We further performed X-ray and magnetic resonance imaging with radiomorphometric assessment. RESULTS: The patients showed beneficial effects concerning low back pain disability (mean ODI score; screening, 68.0 ± 15.8% vs month 12, 42.8 ± 24.5%). The pain level was decreased (VAS vertebral spine score; screening, 68.8 ± 17.6 vs month 12, 43.8 ± 22.2) and the general health state was improved (SF-36; especially ‘role limitations due to emotional problems’ (51.9 ± 44.7; month 6), followed by ‘role limitations due to physical health’ (36.1 ± 42.4; month 6), and ‘pain’ (34.6 ± 35.3; month 6)). No vertebral infection did occur during the hospital stay or the 1-year follow-up. The stabilisation and restoration of the fractured bodies were radiologically confirmed. A reduced rate of leakage was observed, combined with a decreased risk of infection and an improved patient safety after a 1-year follow-up period. CONCLUSION: Requirements for bone cement in a kyphoplasty setting were excellently fulfilled. Application technique and cement properties may influence the success of the surgery. TRIAL REGISTRATION: Deutsche Institut für Medizinische Dokumentation und Information (DIMDI), HM-KS-0901, Registered 14 September 2009, https://www.dimdi.de/dynamic/de/medizinprodukte/datenbankrecherche/
format Online
Article
Text
id pubmed-6660699
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66606992019-08-01 Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty Opalko, Maciej Bösebeck, Hans Vogt, Sebastian J Orthop Surg Res Research Article BACKGROUND: Evidence on antibiotic-loaded bone cement remains too vague to guide kyphoplasty in patient care. We clinically evaluated the properties and benefits of a new low viscosity polymethylmethacrylate (PMMA) bone cement loaded with gentamicin. METHODS: In this non-randomised, monocentric, prospective open trial, 50 consecutively enrolled patients with fractures of the vertebral body (TH7-L4) due to osteoporosis or trauma were investigated between 2010 and 2013, with a 1-year post-op follow-up per patient. The antibiotic-loaded PMMA bone cement was administered to patients during the surgery according to the standard procedure established on site for one-staged kyphoplasty. The clinical outcome was assessed according to function and pain by standardised anamnesis, clinical investigation, validated visual analogue scale (VAS) vertebral spine score, Oswestry Low-Back-Pain (ODI) Disability score, and Short Form (SF)-36 score. We further performed X-ray and magnetic resonance imaging with radiomorphometric assessment. RESULTS: The patients showed beneficial effects concerning low back pain disability (mean ODI score; screening, 68.0 ± 15.8% vs month 12, 42.8 ± 24.5%). The pain level was decreased (VAS vertebral spine score; screening, 68.8 ± 17.6 vs month 12, 43.8 ± 22.2) and the general health state was improved (SF-36; especially ‘role limitations due to emotional problems’ (51.9 ± 44.7; month 6), followed by ‘role limitations due to physical health’ (36.1 ± 42.4; month 6), and ‘pain’ (34.6 ± 35.3; month 6)). No vertebral infection did occur during the hospital stay or the 1-year follow-up. The stabilisation and restoration of the fractured bodies were radiologically confirmed. A reduced rate of leakage was observed, combined with a decreased risk of infection and an improved patient safety after a 1-year follow-up period. CONCLUSION: Requirements for bone cement in a kyphoplasty setting were excellently fulfilled. Application technique and cement properties may influence the success of the surgery. TRIAL REGISTRATION: Deutsche Institut für Medizinische Dokumentation und Information (DIMDI), HM-KS-0901, Registered 14 September 2009, https://www.dimdi.de/dynamic/de/medizinprodukte/datenbankrecherche/ BioMed Central 2019-07-27 /pmc/articles/PMC6660699/ /pubmed/31351477 http://dx.doi.org/10.1186/s13018-019-1200-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Opalko, Maciej
Bösebeck, Hans
Vogt, Sebastian
Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title_full Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title_fullStr Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title_full_unstemmed Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title_short Properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
title_sort properties and clinical application safety of antibiotic-loaded bone cement in kyphoplasty
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660699/
https://www.ncbi.nlm.nih.gov/pubmed/31351477
http://dx.doi.org/10.1186/s13018-019-1200-3
work_keys_str_mv AT opalkomaciej propertiesandclinicalapplicationsafetyofantibioticloadedbonecementinkyphoplasty
AT bosebeckhans propertiesandclinicalapplicationsafetyofantibioticloadedbonecementinkyphoplasty
AT vogtsebastian propertiesandclinicalapplicationsafetyofantibioticloadedbonecementinkyphoplasty